QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)

Syndax Pharmaceuticals (SNDX) Competitors

$19.97
+0.06 (+0.30%)
(As of 05/31/2023 ET)
Compare
Today's Range
$19.80
$20.47
50-Day Range
$19.35
$22.26
52-Week Range
$14.69
$29.86
Volume
1.17 million shs
Average Volume
822,172 shs
Market Capitalization
$1.37 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$33.86

SNDX vs. AGIO, KROS, GERN, PTGX, MLTX, KDNY, GMTX, ZNTL, DVAX, and AUPH

Should you be buying Syndax Pharmaceuticals stock or one of its competitors? The main competitors of Syndax Pharmaceuticals include Agios Pharmaceuticals (AGIO), Keros Therapeutics (KROS), Geron (GERN), Protagonist Therapeutics (PTGX), MoonLake Immunotherapeutics (MLTX), Chinook Therapeutics (KDNY), Gemini Therapeutics (GMTX), Zentalis Pharmaceuticals (ZNTL), Dynavax Technologies (DVAX), and Aurinia Pharmaceuticals (AUPH). These companies are all part of the "pharmaceutical preparations" industry.

Syndax Pharmaceuticals vs.

Agios Pharmaceuticals (NASDAQ:AGIO) and Syndax Pharmaceuticals (NASDAQ:SNDX) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, risk, institutional ownership, profitability, community ranking and analyst recommendations.

Agios Pharmaceuticals has a beta of 0.96, suggesting that its stock price is 4% less volatile than the S&P 500. Comparatively, Syndax Pharmaceuticals has a beta of 1.11, suggesting that its stock price is 11% more volatile than the S&P 500.

Syndax Pharmaceuticals has higher revenue and earnings than Agios Pharmaceuticals. Syndax Pharmaceuticals is trading at a lower price-to-earnings ratio than Agios Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Agios Pharmaceuticals$14.24 million98.67-$231.80 million-$3.97-6.37
Syndax Pharmaceuticals$139.71 million9.84-$149.34 million-$2.41-8.29

Syndax Pharmaceuticals has a net margin of 0.00% compared to Agios Pharmaceuticals' net margin of -1,146.58%. Agios Pharmaceuticals' return on equity of -20.23% beat Syndax Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Agios Pharmaceuticals -1,146.58% -20.23% -18.08%
Syndax Pharmaceuticals N/A -38.25% -35.58%

Agios Pharmaceuticals received 129 more outperform votes than Syndax Pharmaceuticals when rated by MarketBeat users. Likewise, 68.44% of users gave Agios Pharmaceuticals an outperform vote while only 64.79% of users gave Syndax Pharmaceuticals an outperform vote.

CompanyUnderperformOutperform
Agios PharmaceuticalsOutperform Votes
475
68.44%
Underperform Votes
219
31.56%
Syndax PharmaceuticalsOutperform Votes
346
64.79%
Underperform Votes
188
35.21%

In the previous week, Agios Pharmaceuticals had 3 more articles in the media than Syndax Pharmaceuticals. MarketBeat recorded 5 mentions for Agios Pharmaceuticals and 2 mentions for Syndax Pharmaceuticals. Syndax Pharmaceuticals' average media sentiment score of 1.64 beat Agios Pharmaceuticals' score of 1.48 indicating that Syndax Pharmaceuticals is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Agios Pharmaceuticals
4 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Syndax Pharmaceuticals
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

99.1% of Syndax Pharmaceuticals shares are owned by institutional investors. 4.2% of Agios Pharmaceuticals shares are owned by insiders. Comparatively, 4.7% of Syndax Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Agios Pharmaceuticals currently has a consensus price target of $37.00, indicating a potential upside of 46.36%. Syndax Pharmaceuticals has a consensus price target of $33.86, indicating a potential upside of 69.54%. Given Syndax Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe Syndax Pharmaceuticals is more favorable than Agios Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Agios Pharmaceuticals
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75
Syndax Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Syndax Pharmaceuticals beats Agios Pharmaceuticals on 11 of the 18 factors compared between the two stocks.


New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SNDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SNDX vs. The Competition

MetricSyndax PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$1.37B$5.72B$4.49B$6.12B
Dividend YieldN/A2.71%2.32%6.16%
P/E Ratio-8.297.98117.0913.80
Price / Sales9.84320.193,614.4486.45
Price / CashN/A20.5595.04107.29
Price / Book3.155.135.027.11
Net Income-$149.34M$188.97M$117.68M$193.34M
7 Day Performance-6.64%-1.85%-1.71%-0.65%
1 Month Performance-2.82%2.04%0.73%1.17%
1 Year Performance21.03%14.92%18.54%-0.78%

Syndax Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AGIO
Agios Pharmaceuticals
2.0662 of 5 stars
$27.12
+1.6%
$37.00
+36.4%
+27.7%$1.51B$14.24M-6.83390Positive News
KROS
Keros Therapeutics
2.333 of 5 stars
$50.58
+3.4%
$103.75
+105.1%
+38.4%$1.50B$20.10M-11.5060
GERN
Geron
2.0551 of 5 stars
$3.07
-2.5%
$5.00
+62.9%
+137.1%$1.56B$494,000.00-9.0369Positive News
PTGX
Protagonist Therapeutics
2.2583 of 5 stars
$25.20
-1.6%
$35.67
+41.5%
+186.2%$1.44B$26.58M-8.87118
MLTX
MoonLake Immunotherapeutics
1.5801 of 5 stars
$27.35
+1.0%
$25.29
-7.5%
+337.1%$1.44BN/A-23.78N/AHigh Trading Volume
KDNY
Chinook Therapeutics
2.011 of 5 stars
$21.54
-2.6%
$37.00
+71.8%
+57.3%$1.44B$6.13M-6.75138
GMTX
Gemini Therapeutics
0 of 5 stars
$33.20
-1.0%
N/A+2,481.7%$1.44BN/A-33.2031Gap Up
ZNTL
Zentalis Pharmaceuticals
1.5418 of 5 stars
$26.74
-2.1%
$46.00
+72.0%
+6.9%$1.59BN/A-6.23177
DVAX
Dynavax Technologies
2.4452 of 5 stars
$11.08
+0.8%
$24.00
+116.6%
-9.7%$1.41B$722.68M7.10311Positive News
AUPH
Aurinia Pharmaceuticals
2.2489 of 5 stars
$11.31
+0.3%
$13.00
+14.9%
-24.1%$1.61B$146.81M-16.88300Short Interest ↓

Related Companies and Tools

This page (NASDAQ:SNDX) was last updated on 5/31/2023 by MarketBeat.com Staff

My Account -